A detailed history of Grand Central Investment Group transactions in Johnson & Johnson stock. As of the latest transaction made, Grand Central Investment Group holds 48,501 shares of JNJ stock, worth $7.98 Million. This represents 11.04% of its overall portfolio holdings.

Number of Shares
48,501
Previous 48,368 0.27%
Holding current value
$7.98 Million
Previous $8.59 Million 7.72%
% of portfolio
11.04%
Previous 12.36%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 10, 2022

BUY
$161.33 - $179.52 $21,456 - $23,876
133 Added 0.27%
48,501 $7.92 Million
Q2 2022

Jul 13, 2022

SELL
$168.19 - $186.01 $9,923 - $10,974
-59 Reduced 0.12%
48,368 $8.59 Million
Q2 2021

Aug 09, 2021

SELL
$159.48 - $171.07 $372,066 - $399,106
-2,333 Reduced 4.6%
48,427 $7.98 Million
Q4 2020

Feb 11, 2021

BUY
$137.11 - $157.38 $6.96 Million - $7.99 Million
50,760 New
50,760 $7.99 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $430B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Grand Central Investment Group Portfolio

Follow Grand Central Investment Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Grand Central Investment Group, based on Form 13F filings with the SEC.

News

Stay updated on Grand Central Investment Group with notifications on news.